Sitemap - 2015 - Mendelspod
Cancer: Year in Review 2015 with Anna Barker
Sci-Fi Author Kim Stanley Robinson Talks Life Science 2015
Yes to FDA Regulation of LDTs, But We Need a New Framework, Says David Spetzler
Genomics and the Cloud Going Through “a Second Puberty,” says AWS’ Angel Pizarro
Hot Biotech Market Neglects Stem Cell Therapies, Says CIRM's Neil Littman
The Future of Diagnostics Reimbursement with Bruce Quinn
Framingham for the Modern Era: Josie Briggs on the Precision Medicine Initiative
Do Alternate Proposals to Regulate LDTs Stand a Chance?
Does the Reproducibility Project in Cancer Biology Offer a Model for a New Kind of Science Auditing?
After CMS Announcement, Peter Maag and CareDx Fight for Life
The Goal Is De Novo Assembly in the Clinic, Says Jim Lupski, Baylor
Cliff Reid Says New Supersequencer Leads the Pack for High Throughput Clinical Sequencing
Defending the Value of Biotech Innovation in California: Sara Radcliffe, CLSA
Long Read Sequencing Dramatically Improves Blood Matching: Steven Marsh, Anthony Nolan Institute
The World of DIY Genomics with K T Pickard
Sequencing in Space: Chris Mason, Cornell
Is the Future of Biology a Return to Chemistry? Carolyn Bertozzi, Stanford
Going Beyond the $1,000 Genome with Mark Gerstein
Creating the Foundation of Genomics: Marc Salit, NIST
Still Unhappy with FDA’s Plan to Regulate LDTs, Professional Lab Groups Go Direct to the Senate
A Diagnostic Success Story with Alka Chaubey, Greenwood Genetic Center
With Two New Easy-to-Use Sequencing Instruments, Thermo Readies for Primetime in the Clinic
Is This the Future of Clinical Trials for Cancer? Stanley Hamilton on the NCI’s New MATCH Trial
Brian Kennedy and Aubrey de Grey on their Converging Approaches to Aging Research
The Business of Aging and Three Reasons Why the FDA Drug Approval Rate Is So High
New York Genome Center’s Nathan Pearson on Public Outreach for Genomics
Tim Triche on Using Arrays for Cancer Research
Thermo’s Chris Linthwaite on Sequencing the Ebola Virus and the Future of Public Health
A Tool to Strengthen the Voice of Science in Online Journalism
Father of Child with Rare Disease Says Science Equals Medicine
Bina CEO Details Secret to Success in NGS Informatics
Cancer Researcher Tim Triche on the Staying Power of Microarrays
Want Answers? Look to the Non-Coding Region of the Genome, Says Cancer Researcher, Tim Triche
Ivan Oransky on Today's Retraction Boom
Genomics-Palooza, Diagnostics Fraud, and Biblical Prophets on the Future of Biotech
We Got Research, PCSK9 Inhibitors, and Clinical Trials for Religion
The Multi-Platform Approach to Clinical Sequencing with Bobby Sebra, Icahn School
So That Happened, The Mad Genius, and Selling SynBio
Summer Genomics Festival, the Other Sports Genes, and Brain Surgery for Fruit Flies
The Sports Genes with Jeremy Koenig, Athletigen
Woodstock for Genomics? Richard Lumb and Carl Smith on this Month’s Festival
Geneticists Anonymous, the Sad State of Science Journalism, and New Kids on the Helix
The 9 Billion People Problem: Rod Wing on Plant Genomics
Should We Hold Back the Reins on Biotechnology? with Chris Gunter
Are We Ready to Trust Liquid Biopsies? with Milena Cankovic, Henry Ford Hospital
Gene and Tonic: Boxing for Cancer, Dubious Correlations, and When Should a Researcher Retire
New Patient Focused Genome Magazine Signing up Many Doctors Too
Gene and Tonic: Sexism in Science, How to Spend an NIH Budget Increase, How Not to Spend It
Participation in Genomics Research a 21st Century Public Good, Says Paul Billings of Omicia
Gene and Tonic: Competition for 23andMe, Four Tips for Attending AACR 2015, and "Swab Stories"
Improving the Backbone of Clinical Genomics : Valerie Schneider, NCBI
Behind the Sequencing Bench with Dale Yuzuki
Gene and Tonic: The Tenth Commandment of Science, Icelandic Treasure, and TechBio Babies
It’s Pretty Bad: Andy Brooks of RUCDR on Sample Quality
Knowing More about What We Don’t Know: John McPherson on Cancer Genomics
Gene and Tonic: The iWatch and Research Kit, 23andMe Goes for the Big Time, No Spaceship
In Partnership with IBM’s Watson, Pathway Genomics Reinvents Itself
Affymetrix CEO, Frank Witney, on Arrays in the Age of Sequencing
Gene & Tonic: Disruption in Sequencing, Scientist Politicians, Some Cool Synbio
Changing the World with Color Changing Flowers
Cancer Researcher at Mayo Says Illumina Platform Maxing Out, Looks to BGI/Complete
Returning to Old Biotech Model, OncoMed Boasts of Seven Drugs in Clinical Trials by Mid 2015
Cutting through the Hype in Healthcare Innovation with David Shaywitz and Lisa Suennen
A Call to Consumers to Lead the Shift in Healthcare: Sharon Terry, Genetic Alliance
In Autoimmune Disease, Finding Clarity Beyond the Genome: Stefan Muellner, Protagen
Myriad Settlements Mark End of an Era: Antoinette Konski on Gene Patents
David Schwartz on the Future of Sequencing
Not a Stenographer to Power: Luke Timmerman and the New 'Timmerman Report'
FDA Will Take Time to Digest Comments on LDT Guidance, Says Liz Mansfield
Future of Personalized Medicine at Stake, says Amy Miller of PMC about LDT Regulation
'A Good Year' with John LaMattina